JCP Weekly December 3, 2019

Academic Highlights

Patient-Centered Care for Alzheimer Disease

Learn from experts in neurology, psychiatry, neuropsychology, and primary care about working with patients and care partners to create management plans for Alzheimer’s disease that ensure safety, optimize patient autonomy, and minimize agitation and conflict.

DOI: 10.4088/JCP.MS18002AH3C | Posted: 12/03/2019

Clinical and Practical Psychopharmacology

Augmentation With Memantine in OCD

A recent meta-analysis found substantial benefits of memantine in treating obsessive-compulsive disorder. Dr Andrade takes a closer look at the methods the authors used and the studies they included to weigh the merits of their conclusions.

DOI: 10.4088/JCP.19f13163 | Posted: 12/03/2019



This commentary discusses the findings and implications of a recent post hoc study by Thase and colleagues on the utility of combinatorial pharmacogenomics in depression.

DOI: 10.4088/JCP.19com13119 | Posted: 12/03/2019

Original Research

Model of Prescription Opioid Use Disorder

Prior research has identified several risk factors for prescription opioid use disorder (POUD). The authors attempted to develop a conceptual model for POUD based on an existing model for major depression—check out the article for details.

DOI: 10.4088/JCP.19m12775 | Posted: 12/03/2019

Educational Activity

Psychosocial Implications of Tardive Dyskinesia

How does tardive dyskinesia affect patients' work and relationships? Should TD be treated even if patients lack insight into its presence? Dr Joseph McEvoy considers these questions and more in this brief CME activity.

DOI: 10.4088/JCP.NU18041BR2C | Posted: 12/03/2019

See past JCP Weekly